论文信息 - Pharmacokinetics of flumazenil in fulminant hepatic failure - 字舞流文

Pharmacokinetics of flumazenil in fulminant hepatic failure

S. Schalm | R. H. Drost | C. C. D. Rijt | M. Schramel

[1] U. Klotz,et al. Flumazenil disposition and elimination in cirrhosis. , 1990, Clinical pharmacology and therapy.

[2] R. Butterworth,et al. Pharmacokinetics of benzodiazepine antagonist Ro 15–1788 in cirrhotic patients with moderate or severe liver dysfunction , 1989, Hepatology.

[3] P. Meier,et al. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. , 1989, Gastroenterology.

[4] C. Madl,et al. IMPROVEMENT OF HEPATIC ENCEPHALOPATHY TREATED WITH FLUMAZENIL , 1988, The Lancet.

[5] W. Ziegler,et al. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. , 1986, British journal of clinical pharmacology.

[6] U. Klotz,et al. Pharmacodynamic Interaction Between Midazolam and a Specific Benzodiazepine Antagonist in Humans , 1985, Journal of clinical pharmacology.

[7] P. Meier,et al. REVERSAL OF HEPATIC COMA BY BENZODIAZEPINE ANTAGONIST (Ro 15-1788) , 1985, The Lancet.

[8] U. Klotz,et al. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man , 2004, European Journal of Clinical Pharmacology.

[9] T. Duka,et al. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788. , 1985, British journal of clinical pharmacology.